Email this article Primary hyperparathyroidism clinical features on endocrinology in-patients clinic
- Authors: Sapozhnikova IE1
-
Affiliations:
- Kirov State Medical University, the Ministry of Health of the Russia
- Issue: Vol 90, No 10 (2018)
- Pages: 51-54
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32860
- DOI: https://doi.org/10.26442/terarkh201890104-54
- ID: 32860
Cite item
Full Text
Abstract
Aim. The analysis clinical features of primary hyperparathyroidism on endocrinology in-patients clinic. Materials and methods. Open retrospective study, included data of patients who were hospitalized at Kirov Regional Hospital with primary hyperparathyroidism from January 01, 2013 to December 31, 2016. Results and discussion. 23 patients were hospitalized. Their age is 24-78 years old (mediana 59 [52; 65] years old). There are 20 (87%) women, and 3 (13%) men. Manifest forms of primary hyperparathyroidism were detected in 18 (78.3%) patients, mild forms - in 5 (21.7%) patients. Pathological fracture had 7 (30.4%) patients including 3 (13%) vertebrae and hip fracture, urolithiasis had 10 (43.5%) persons. High blood calcium or parathyroma in ultra-sound were initially revealed in 8 (34.8%) patients 4 (50%) of them had manifest primary hyperparathyroidism. Period before diagnosis was 2 years and more in 10 (43.5%) patients. Conclusion. Clinical features of primary hyperparathyroidism are prevalence of manifest forms, late diagnosis, and high enough frequent of accidental reveal (including persons with representative symptoms).
Full Text
##article.viewOnOriginalSite##About the authors
I E Sapozhnikova
Kirov State Medical University, the Ministry of Health of the Russia
Email: kgma@sapir.kirov.ru
к.м.н., доц каф. госпитальной те-рапии, врач-эндокринолог, ORCID: 0000-0002-1606-918X Kirov, Russia
References
- Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., Рожинская Л.Я., Кузнецов Н.С., Пигарова Е.А., Еремкина А.К., Егшатян Л.В., Мамедова Е.О., Крупинова Ю.А. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения. Проблемы эндокринологии. 2016;62(6):40-77. doi: 10.14341/probl201662640-77
- Дедов И.И., Васильева Т.О., Рожинская Л.Я., Мокрышева Н.Г. Эпидемиология первичного гиперпаратиреоза. Проблемы эндокринологии. 2010;56(5):3-7. doi: 10.14341/probl20105653-7
- Дедов И.И., Мельниченко Г.А., редакторы. Национальное руководство по эндокринологии. Москва: ГЭОТАР-Медиа; 2013: С. 548-555, 590-599.
- Дедов И.И., Рожинская Л.Я., Мокрышева Н.Г., Васильева Т.О. Этиология, патогенез, клиническая картина, диагностика и лечение первичного гиперпаратиреоза. Остеопороз и остеопатии. 2010;13(1):13-18. doi: 10.14341/osteo2010113-18
- Silverberg S.J, Walker M.D, Bilezikian J.P. Asymptomatic primary hyperparathyroidism. J Clin Densitom. 2013;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005
- Мокрышева Н.Г., Рожинская Л.Я., Перетокина Е.В., Ростомян Л.Г., Мирная С.С., Пронин В.С., Маркина Н.В., Шебешева Е.Н., Анциферов М.Б., Дедов И.И. Анализ основных эпидемиологических характеристик первичного гиперпаратиреоза в России (по данным регистра). Проблемы эндокринологии. 2012;58(5):16-20. doi: 10.14341/probl201258516-20
- De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, Parikh N, Rao D.S. Effect of gender and geographic location on the expression of primary hyperparathyroidism. J Endocrinol Invest. 2013;36:123-126. doi: 10.3275/8455
- Yeh M.W, Ituarte P.H, Zhou H.C, Nishimoto S, Liu I.L, Harari A, Haigh P.I, Adams A.L. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98:1122-1129. doi: 10.1210/jc.2012-4022
- Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377-2385. doi: 10.1210/jc.2011-0569
- Walker M.D, Fleischer J.B, Di Tullio M.R, Homma S, Rundek T, Stein E.M, Zhang C, Taggart T, Mc Mahon D.J, Silverberg S.J. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2010;95:2172-2179. doi: 10.1210/jc.2009-2072
